|
Natco Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
15804.65 Cr.
|
P/BV
|
1.69
|
Book Value (Rs.)
|
521.65
|
|
52 Week High/Low (Rs.)
|
1227/789
|
FV/ML
|
2/1
|
P/E(X)
|
11.14
|
|
Bookclosure
|
20/08/2026
|
EPS (Rs.)
|
79.20
|
Div Yield (%)
|
0.57
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4078.30 | 4411.60 | 3978.80 | 2696.90 | 1904.90 |
| Other Operating Revenues | 0.00 | 17.90 | 20.00 | 10.20 | 39.90 |
| Total Operating Revenues | 4078.30 | 4429.50 | 3998.80 | 2707.10 | 1944.80 |
| | | | | | |
| Other Income | 297.60 | 354.50 | 128.10 | 104.60 | 99.00 |
| Total Revenue | 4375.90 | 4784.00 | 4126.90 | 2811.70 | 2043.80 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 593.50 | 536.20 | 522.50 | 475.30 | 519.20 |
| Purchase Of Stock-In Trade | 203.20 | 166.10 | 151.40 | 175.70 | 58.50 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -106.20 | -12.50 | 42.70 | -23.70 | -16.80 |
| Employee Benefit Expenses | 687.20 | 594.50 | 525.00 | 486.70 | 444.80 |
| Finance Costs | 36.70 | 23.90 | 19.20 | 14.50 | 17.70 |
| Depreciation And Amortisation Expenses | 206.60 | 235.20 | 186.80 | 163.80 | 142.60 |
| Other Expenses | 1264.10 | 949.20 | 1005.80 | 657.50 | 675.60 |
| Total Expenses | 2885.10 | 2492.60 | 2453.40 | 1949.80 | 1841.60 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1490.80 | 2291.40 | 1673.50 | 861.90 | 202.20 |
| | | | | | |
| Profit/Loss Before Tax | 1490.80 | 2291.40 | 1673.50 | 861.90 | 202.20 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 118.90 | 437.60 | 316.50 | 162.70 | 47.80 |
| Deferred Tax | 0.00 | -29.60 | -31.30 | -16.10 | -15.60 |
| Total Tax Expenses | 118.90 | 408.00 | 285.20 | 146.60 | 32.20 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1371.90 | 1883.40 | 1388.30 | 715.30 | 170.00 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1371.90 | 1883.40 | 1388.30 | 715.30 | 170.00 |
| | | | | | |
| Profit/Loss For The Period | 1371.90 | 1883.40 | 1388.30 | 715.30 | 170.00 |
| | | | | | |
| Minority Interest | 0.00 | 2.00 | 0.00 | 0.00 | 0.00 |
| Share Of Profit/Loss Of Associates | 46.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 1418.50 | 1885.40 | 1388.30 | 715.30 | 170.00 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 79.20 | 105.26 | 77.34 | 39.18 | 9.32 |
| Diluted EPS (Rs.) | 79.20 | 105.26 | 77.34 | 39.18 | 9.32 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 107.50 | 170.20 | 100.40 | 82.10 |
